Legge, Francesco
 Distribuzione geografica
Continente #
EU - Europa 456
NA - Nord America 372
AS - Asia 311
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
AF - Africa 1
Totale 1145
Nazione #
US - Stati Uniti d'America 371
CN - Cina 285
PL - Polonia 142
DE - Germania 120
UA - Ucraina 59
SE - Svezia 46
GB - Regno Unito 29
IT - Italia 19
FR - Francia 18
FI - Finlandia 12
IN - India 11
JP - Giappone 7
TR - Turchia 5
RU - Federazione Russa 3
BE - Belgio 2
EU - Europa 2
IR - Iran 2
A1 - ???statistics.table.value.countryCode.A1??? 1
AR - Argentina 1
AT - Austria 1
BR - Brasile 1
CA - Canada 1
GR - Grecia 1
MA - Marocco 1
NL - Olanda 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
Totale 1145
Città #
Hangzhou 169
Warsaw 142
Chandler 49
Beijing 43
Jacksonville 36
San Mateo 31
Ashburn 29
Nanjing 28
Houston 27
Wilmington 21
Fairfield 18
Woodbridge 17
Lancaster 16
Ann Arbor 15
Boston 12
Dearborn 11
Lawrence 11
Cambridge 10
Redwood City 8
Nanchang 7
Seattle 7
Cattolica 5
Izmir 5
Nürnberg 5
Falls Church 4
Lanzhou 4
Milan 4
Mountain View 4
Norwalk 4
Shenyang 4
Tianjin 4
Hebei 3
Jinan 3
Kunming 3
Rühen 3
Simi Valley 3
University Park 3
Zhengzhou 3
Andover 2
Ardabil 2
Augusta 2
Brussels 2
Changsha 2
Guangzhou 2
Hefei 2
Hilter 2
Leawood 2
Munich 2
Princeton 2
San Francisco 2
Shanghai 2
Athens 1
Auburn Hills 1
Bangalore 1
Baotou 1
Berlin 1
Civitavecchia 1
Denver 1
Fontenay-sous-bois 1
Fuzhou 1
Helsinki 1
Indiana 1
Jiaxing 1
Lachine 1
Lisbon 1
Mangalore 1
Manila 1
Minoh 1
Montesarchio 1
Mumbai 1
Nanning 1
Napoli 1
Palermiti 1
Palermo 1
Rabat 1
Rome 1
Saint Paul 1
Saint Petersburg 1
Sterling 1
Tettnang 1
Torino 1
Totale 827
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 762
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 274
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 88
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 76
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 59
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 58
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. 54
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients 49
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 48
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 48
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 46
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 38
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 30
Totale 1630
Categoria #
all - tutte 1963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201898 0000 117 917 245421
2018/2019186 12231827 1718 228 6111410
2019/2020568 32101429 2460 9164 89574355
2020/2021323 5447738 327 165 21284919
2021/2022164 341709 47 427 8111726
2022/2023114 45411612 00 00 0000
Totale 1630